What are the indications, contraindications, and components of fiberoptic bronchoscopy (FOB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fiberoptic Bronchoscopy: Indications, Contraindications, and Components

Fiberoptic bronchoscopy (FOB) is indicated for both diagnostic and therapeutic purposes, with diagnostic uses including suspected malignancy, tuberculosis, and diffuse lung disease, while therapeutic applications include secretion clearance and foreign body removal. 1

Indications

Diagnostic Indications

  • Suspected bronchial malignancy: Obtain at least 5 bronchial biopsies plus brushings and washings to achieve minimum 80% diagnostic yield 1
  • Suspected tuberculosis: Particularly in high-burden settings where diagnostic yield reaches 41.4% 2
  • Diffuse lung disease: Obtain 4-6 transbronchial biopsy samples from one lung 1
  • Airway inspection: Direct visualization of airways for structural abnormalities 2
  • Pneumonia diagnosis in ICU: Bronchoscopically directed lavage or brushing for microbiological sampling 1
  • Hemoptysis evaluation: Identify source and extent of bleeding (though massive hemoptysis requires rigid bronchoscopy) 1

Therapeutic Indications

  • Secretion clearance: Particularly effective with N-acetylcysteine instillation for thick secretions 1
  • Foreign body removal: Food material or tooth fragments using wire basket or forceps 1
  • Atelectasis management: Though more controversial 3
  • Endotracheal tube positioning: Check or replace tubes in ventilated patients 4

Contraindications and High-Risk Situations

Relative Contraindications (Proceed with Extreme Caution)

Recent myocardial infarction: Avoid during acute ischemia; if performed within 12 days post-MI, use continuous oxygen, ECG monitoring, and adequate sedation 1

Severe COPD: Check spirometry before procedure; if FEV1 <40% predicted and/or SaO2 <93%, measure arterial blood gases. Complication rate increases to 5% versus 0.6% in normal lung function 1

Coagulation abnormalities: Elevated PT, increased APTT, reduced fibrinogen, or thrombocytopenia make biopsy procedures hazardous—consider brushing or lavage only 1

Asthma: Premedicate with bronchodilator before procedure; 8% risk of laryngospasm or bronchospasm 1

Absolute Contraindications

  • Active acute ischemia or unstable angina
  • Inability to adequately oxygenate the patient
  • Uncooperative patient without ability to sedate safely

Components and Technical Requirements

Equipment

  • Flexible fiberoptic bronchoscope: Primary visualization tool
  • Swivel adapter: For intubated patients to prevent loss of oxygen and tidal volume 4
  • Biopsy forceps: At least 5 specimens for suspected malignancy 1
  • Brushes: For cytology and microbiology
  • Wire basket: For foreign body retrieval 1

Staffing Requirements

At least two endoscopy assistants must be present, with at least one being a qualified nurse 1

Medications

  • Lignocaine (lidocaine): Maximum dose 8.2 mg/kg (approximately 29 ml of 2% solution for 70 kg patient); use extra caution in elderly or those with liver/cardiac impairment 1
  • Bronchodilator: Mandatory premedication for asthmatic patients 1
  • Prophylactic antibiotics: Required for asplenic patients, prosthetic heart valves, or previous endocarditis 1

Monitoring Requirements

  • Continuous multi-modal physiological monitoring during and after procedure 1
  • ECG for heart rate and rhythm
  • Continuous intra-arterial or intermittent cuff blood pressure
  • Pulse oximetry (SpO2)
  • Intracranial pressure monitoring in head-injured patients 1

Safety Considerations

Overall Safety Profile

Flexible bronchoscopy is extremely safe with mortality rate 0.01-0.04% and major complication rate 0.08-0.12% 1

Specific Complications

  • Pneumothorax: 3-3.5% with transbronchial biopsy; increases to 14% in mechanically ventilated patients; 50% require drainage 1
  • Hemorrhage: 9% with transbronchial biopsies 1
  • Hypoxemia: PaO2 fall of approximately 2.5 kPa is common; provide supplemental oxygen for 1-2 hours post-procedure 1
  • Bacteremia: 6.5% during procedure 1
  • Bronchospasm: 0.02% generally, but 8% in asthmatic patients 1

ICU-Specific Considerations

Patients in ICU are high-risk for complications 1. Pre-oxygenate with 100% oxygen, adjust ventilator to mandatory mode, increase pressure limits, and increase ventilator rate as needed 1

Patient Preparation

  • Fasting: No food for 4 hours; clear fluids allowed up to 2 hours before procedure 1
  • Written and verbal information: Improves tolerance 1
  • Post-procedure restrictions: No driving, signing legal documents, or operating machinery for 24 hours after sedation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.